ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,505, issued on Aug. 12, was assigned to UNIVERSITY OF SOUTH CAROLINA (Columbia, S.C.).

"Nanoparticle for the remodeling of cancer-associated fibroblasts" was invented by Peisheng Xu (Chapin, S.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are systems and methods for employing a tumor targeted cerium oxide nanoparticle system, T-CeNP, for cancer therapy to hinder cancer associated fibroblast (CAF) transdifferentiation and reprogram CAFs back to normal fibroblasts to reduce tumor size and prevent metastasis."

The patent was filed on Oct. 14, 2022, under Application No. 17/965,880.

*For further information, including images, char...